Denis Delval
Amministratore Delegato presso LFB Biomedicaments SA
Profilo
Denis Delval is currently the President & Chief Executive Officer at Ethypharm SAS since 2022 and also holds the position of Chairman & Chief Executive Officer at LFB Biomedicaments SA since 2017.
Previously, he was the Chairman & Chief Executive Officer at LFB Biotechnologies SASU and the Chief Executive Officer at Laboratoire Français du Fractionnement et des Biotechnologies.
Dr. Delval holds a doctorate degree from INSEAD and an undergraduate degree from ESSEC Business School.
Posizioni attive di Denis Delval
| Società | Posizione | Inizio |
|---|---|---|
LFB Biomedicaments SA
 LFB Biomedicaments SA Pharmaceuticals: MajorHealth Technology LFB Biomedicaments SA is a French pharmaceutical company that manufactures pharmaceutical preparation products. The company is a subsidiary of the Government of France and is based in Les Ulis, France. The company was founded in 2006 and Denis Delval has been the CEO of the company since 2017. | Amministratore Delegato | 23/12/2017 |
Ethypharm SAS
 Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | Amministratore Delegato | 10/10/2022 |
Precedenti posizioni note di Denis Delval
| Società | Posizione | Fine |
|---|---|---|
LFB Biotechnologies SASU
 LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Amministratore Delegato | - |
Laboratoire Français du Fractionnement et des Biotechnologies
 Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Amministratore Delegato | - |
Formazione di Denis Delval
| ESSEC Business School | Undergraduate Degree |
| INSEAD | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Health Technology |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Health Technology |
LFB Biomedicaments SA
LFB Biomedicaments SA Pharmaceuticals: MajorHealth Technology LFB Biomedicaments SA is a French pharmaceutical company that manufactures pharmaceutical preparation products. The company is a subsidiary of the Government of France and is based in Les Ulis, France. The company was founded in 2006 and Denis Delval has been the CEO of the company since 2017. | Health Technology |
Ethypharm SAS
Ethypharm SAS Pharmaceuticals: MajorHealth Technology Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France. | Health Technology |
- Borsa valori
- Insiders
- Denis Delval
